Tiverton Asset Management’s AstraZeneca AZN Stock Holding History

Tiverton Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$147K	Hold	1,651	–	–	0.01%	590
2019 Q2	$136K	Hold	1,651	–	–	﹤0.01%	593
2019 Q1	$133K	Sell	1,651 -879	-35%	-$69.3K	0.01%	557
2018 Q4	$192K	Hold	2,530	–	–	0.01%	314
2018 Q3	$200K	Hold	2,530	–	–	0.01%	324
2018 Q2	$178K	Buy	+2,530	New	+$182K	0.01%	329

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Tiverton Asset Management's AZN Position: Q3 2019 in Review

Tiverton Asset Management held its AstraZeneca (AZN) position steady in Q3 2019 at 1,651 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #590.

Tiverton Asset Management first reported a position in AZN in Q2 2018 and has held it in 6 quarters since. The position peaked at $200K in Q3 2018. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Tiverton Asset Management held 1,651 shares of AstraZeneca worth $147K as of Q3 2019.
Tiverton Asset Management left its AstraZeneca share count unchanged in Q3 2019.
AstraZeneca made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #590 holding.
Tiverton Asset Management first reported a position in AstraZeneca in Q2 2018 and has held it in 6 quarters since.
Tiverton Asset Management's AstraZeneca position peaked at $200K in Q3 2018.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.